GlassScriptPhysician profile
Arpit Aggarwal
NPI 1356879035
$5,569.57
in general payments reported to CMS, 2019-2025
10 companies · $816 in 2025
The $816 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,361 · 2023: $899 · 2024: $2,494 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,597 · Travel and Lodging: $1,603 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,597.47 |
| Travel and Lodging | $1,602.64 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,029.31 | 2023-2024 | Da Vinci Sp |
| Medtronic, INC. | $1,686.93 | 2022-2025 | Interstim |
| Ethicon US, LLC | $1,012.61 | 2023-2025 | Echelon; Endopath, Echelon Circular, Contour |
| Tela Bio, INC. | $302.13 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acera Surgical, INC. | $159.95 | 2025 | Restrata Wound Matrix |
| Davol INC. | $152.75 | 2022 | |
| Becton, Dickinson and Company | $126.00 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $65.77 | 2025 | Stravix |
| Takeda Pharmaceuticals U.S.A., INC. | $20.41 | 2023 | Entyvio |
| Janssen Biotech, INC. | $13.71 | 2023 | Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpit Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.